Cargando…
Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time?
Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the imp...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489292/ https://www.ncbi.nlm.nih.gov/pubmed/37693304 http://dx.doi.org/10.1097/CCE.0000000000000965 |
_version_ | 1785103648600096768 |
---|---|
author | Cerier, Emily J. Toyoda, Takahide McNulty, Colleen O’Boye, Anne Kurihara, Chitaru Bharat, Ankit Nadig, Nandita R. |
author_facet | Cerier, Emily J. Toyoda, Takahide McNulty, Colleen O’Boye, Anne Kurihara, Chitaru Bharat, Ankit Nadig, Nandita R. |
author_sort | Cerier, Emily J. |
collection | PubMed |
description | Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the implementation of clinical care pathways for intake of these patients. Eighty-seven of 270 patients (32.2%) met screening criteria and were evaluated for transfer within a median of 12 days, during which 38 of 87 patients (43.7%) died and 12 of 87 patients (13.8%) transferred elsewhere. Thirty-seven of 87 patients (42.5%) were accepted for transfer of which 16 of 37 patients (43.2%) successfully transferred to our center with a median transfer waiting period of 12 days. Because of resource constraints, 21 of 37 accepted patients (56.8%) could not be transferred of which 9 of 21 patients (42.9%) died while waiting. Nine of 16 transferred patients (56.2%) eventually underwent lung transplantation with over 80% 6-month survival. ARDS patients referred for transplantation have high risk of mortality and, therefore, require well-described pathways for evaluation and transfer. |
format | Online Article Text |
id | pubmed-10489292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104892922023-09-09 Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? Cerier, Emily J. Toyoda, Takahide McNulty, Colleen O’Boye, Anne Kurihara, Chitaru Bharat, Ankit Nadig, Nandita R. Crit Care Explor Letter to the Editor Transfer of select, medically refractory acute respiratory distress syndrome patients to lung transplant centers requires extensive resources. Here, we report 270 consecutive lung transplant patient referrals to our center for medically refractory ARDS from June 2021 to April 2022, following the implementation of clinical care pathways for intake of these patients. Eighty-seven of 270 patients (32.2%) met screening criteria and were evaluated for transfer within a median of 12 days, during which 38 of 87 patients (43.7%) died and 12 of 87 patients (13.8%) transferred elsewhere. Thirty-seven of 87 patients (42.5%) were accepted for transfer of which 16 of 37 patients (43.2%) successfully transferred to our center with a median transfer waiting period of 12 days. Because of resource constraints, 21 of 37 accepted patients (56.8%) could not be transferred of which 9 of 21 patients (42.9%) died while waiting. Nine of 16 transferred patients (56.2%) eventually underwent lung transplantation with over 80% 6-month survival. ARDS patients referred for transplantation have high risk of mortality and, therefore, require well-described pathways for evaluation and transfer. Lippincott Williams & Wilkins 2023-09-07 /pmc/articles/PMC10489292/ /pubmed/37693304 http://dx.doi.org/10.1097/CCE.0000000000000965 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter to the Editor Cerier, Emily J. Toyoda, Takahide McNulty, Colleen O’Boye, Anne Kurihara, Chitaru Bharat, Ankit Nadig, Nandita R. Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? |
title | Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? |
title_full | Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? |
title_fullStr | Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? |
title_full_unstemmed | Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? |
title_short | Single-Center Experience With Lung Transplant Evaluation Referrals of Acute Respiratory Distress Syndrome Patients During the COVID-19 Pandemic: How Do You Make Up For Lost Time? |
title_sort | single-center experience with lung transplant evaluation referrals of acute respiratory distress syndrome patients during the covid-19 pandemic: how do you make up for lost time? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489292/ https://www.ncbi.nlm.nih.gov/pubmed/37693304 http://dx.doi.org/10.1097/CCE.0000000000000965 |
work_keys_str_mv | AT cerieremilyj singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime AT toyodatakahide singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime AT mcnultycolleen singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime AT oboyeanne singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime AT kuriharachitaru singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime AT bharatankit singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime AT nadignanditar singlecenterexperiencewithlungtransplantevaluationreferralsofacuterespiratorydistresssyndromepatientsduringthecovid19pandemichowdoyoumakeupforlosttime |